Services
As a reliable and trusted contract research organization, Creative Biolabs has accumulated extensive experience in the discovery and development of optimized therapeutic antibodies and proteins such as monoclonal antibody, bispecific antibody, anti-idiotype antibody, antibody-drug conjugates, and enzymes, cytokines, or membrane proteins etc. Relying on the expertise of senior scientists with more than 10 years of experience and best-in-class equipment, our unique modules of integrated services enables us to guide our clients through antibody or protein drug discovery challenge from target selection to IND regulatory support.
Integrated solutions for cancer immunotherapy development involve a multidimensional approach that seamlessly combines cutting-edge technologies, collaborative research efforts, and streamlined processes. this comprehensive approach holds the promise of delivering more robust and personalized immunotherapeutic interventions to combat cancer, ushering in a new era of progress in the fight against this complex and challenging disease. Creative Biolabs aims to accelerate the discovery, development, and deployment of innovative immunotherapies for cancer treatment.
Creative Biolabs offers a comprehensive in vitro absorption, distribution, metabolism, and excretion (ADME) service. We provide a wide range of assays, including plasma protein binding, CYP enzyme inhibition and induction, cell permeability, renal excretion, and metabolite analysis. By generating crucial data on how a drug is absorbed, distributed, metabolized, and excreted, we support and accelerate the drug development process, ensuring our clients can bring new therapies to market more efficiently and effectively. With our comprehensive ADME services, clients can make informed decisions, optimize their drug candidates, and streamline their development pipelines.
Creative Biolabs has built a team of experienced scientists with facilities and processes designed specifically to meet every challenging requirement in the study of tumor lymphangiogenesis. We are proficient at inspiring the lymphangiogenic potentiation of immunotherapy to turn cancer cells against themselves. Our years of experience, deep resources, and flexible service options will help deliver fast, reliable support for any phase of your project. We are glad to serve our global clients with professionalism and expertise in this field.
Creative Biolabs is committed to providing rapid, reliable tumor profiling insights for laboratories worldwide and helping make your next cancer treatment breakthrough. We have built a team of experienced scientists with a powerful platform designed specifically to meet every challenging requirement for tumor profiling. We offer sophisticated analysis and provide unique insights into dynamic changes in tumor molecular architecture during tumor progression and under treatment. Our cutting-edge tumor molecular profiling technologies have considerable potential in cancer diagnosis, biomarker discovery, personalized treatment, and prognostic assessment.
The gut microbiome is an extremely promising area for the generation of new diagnostics, prognostics, and therapeutics. More and more studies have now connected dysfunction with microbiome profiles at the disease site, which was initially believed to be independent of microorganisms. Microbiome-based diagnostics allow the detection of human disease using microbial signatures of different types. Scientists at Creative Biolabs are proficient at applying next-generation sequencing (NGS), mass spectrometry, immunoassays, or protein array to facilitate the application of gut microbiome science to medical microbiology and clinical chemistry. We offer turn-key or ala carte services customized to our client's needs.
The early development of the brain, the immune system, and the gut are closely interrelated. Bacteria in the gut cooperate with the immune system. In turn, the immune system monitors gut microbes and develops appropriate responses to them. In addition, the gut interacts with the brain via the vagus nerve as well as via the immune system. With years of research in brain-immune-gut-based integrative research, Creative Biolabs is confident in providing an integrated solution to best suit our clients' program requirements. Our scientists are committed to providing custom brain-immune-gut assay portfolio services.
Human oncology imaging is a comprehensive service integrating medical imaging, equipment analysis, and computer simulation, which can indirectly reflect the changes of genes or proteins at the microscopic level of tumors and provide relative qualitative or quantitative tumor information. Also, the obtained data can assist tumor diagnosis to achieve a more comprehensive, deeper, and more thorough understanding and understanding of the occurrence and development of various tumors. Creative Biolabs is a leader in the field of oncology research and has focused on tumor imaging and lineage tracing services for years. We have experienced experts and advanced platforms that can provide excellent services.
In recent years, outstanding progress has been made in the field of tumor metabolism research. The role of metabolic changes in cancer development and progression has been increasingly recognized and attracts more and more interest from researchers in exploring and targeting tumor metabolism for therapeutic purposes. As a leading company in the bio-industry, Creative Biolabs is dedicated to providing state-of-the-art solutions for tumor metabolism research and cancer treatment. Our comprehensive suite of services and cutting-edge technologies enable researchers to unravel the complex mechanisms underlying tumor metabolism, identify new therapeutic targets, and develop more effective cancer treatments.
Ferroptosis not only plays an important role in the occurrence and development of major chronic diseases but also plays different roles in cancer backgrounds. Currently, it is believed that ferroptosis can inhibit tumor growth and increase the sensitivity of many tumors to chemotherapy drugs and immunotherapy, so the induction of ferroptosis has expanded the idea of tumor treatment. As a top CRO company, Creative Biolabs has established a comprehensive tumor ferroptosis analysis platform to systematically develop novel ferroptosis targets, mechanisms of action, and immunotherapies.
Graft-versus-host disease (GVHD) is the main cause of complications and mortality after allogeneic haematopoietic cell transplantation (HCT). It occurs when donor T cells respond to incompatibility antigens of host tissue. Creative Biolabs can provide a new solution for GVHD predictive, evaluation, and diagnosis analysis. Nowadays, we use mass spectrometry to screen GVHD markers, develop novel therapies, analyze metabolites to provide accurate support for the treatment of GVHD.
Welcome to our cancer resistance integrated solutions! Creative Biolabs can provide one-stop cancer resistance research solutions to help combat cancer and enhance resistance to the disease. We are committed to finding innovative solutions and personalized project options for our clients. From advanced diagnostics to targeted therapies, we offer a comprehensive approach to tackling cancer from all angles.
References
-
Durgan, D.J.; et al. Examining the role of the microbiota-gut-brain axis in stroke. Stroke. 2019, 50(8): 2270-7.
-
Arfin, Saniya, et al. "Oxidative stress in cancer cell metabolism." Antioxidants 10.5 (2021): 642.
For Research Use Only | Not For Clinical Use
Related Services